D epression and anxiety are common and potentially disabling illnesses ( Gelenberg, 2010 ; Hopko et al., 2000 ) . The availability of multiple treatment options and the lack of objective tests to diagnose and assess severity of symptoms make management of these illnesses a challenge in clinical practice ( Dunlop et al., 2010 ) . Results from the Prevention of Recurrent Episodes of Depression With Venlafaxine Extended Release for Two Years trial reported fair rates of agreement between patient and clinician ratings for measures of depression severity ( Dunlop et al., 2010 ) ; the discrepancy may be greater in clinical practice. Although patient-rated scales are convenient and time effi cient, it is important to determine whether patient ratings are consistent with those of clinician-administered rating scales for measuring symptoms. Clinical trials, through repetitive application of rating scales, provide a source of substantial education for patients and serve to align physician and patients in their respective views of an illness. In contrast, clinical practice, which involves much briefer and less-frequent contact, is less likely to benefi t from this educational component, making it likely that agreement in clinical practice would be lower than the published agreement data might suggest.
Disease-specifi c programs (DSPs) are large, multinational studies of clinical practice. They provide robust, real-world data regarding prevalence, severity, and associated treatment practices for a range of common chronic disease areas (Anderson, Benford, Harris, Karavali, & Piercy, 2008) . Patient-level data on behavior, attitudes, and treatment outcomes are collected from both physicians and patients, allowing for unique comparisons of these two perspectives ( Anderson et al., 2008 ) . Disease-specifi c program data comprising real-world observations of clinician-and patient-reported outcomes have been used to yield useful information for attaining asthmatreatment goals (Small, Anderson, Vickers, Kay, & Fermer, 2011; Small, Vickers, Anderson, & Kay, 2010) .
The current analysis was conducted by Adelphi Real World (Macclesfi eld, United Kingdom), as part of the Neuroses DSP, a study covering anxiety and depression in clinical practice. The purpose of this analysis was to compare patient-rated and clinician-rated measures of clinical improvement with antidepressant treatment in real-world clinical practice. The analysis was designed to address these questions: Is there discrepancy between patients' and clinicians' ratings of patient improvement with antidepressant treatment, and is the degree of discordance affected by baseline symptom severity?
M ETHODS

Study Design
The Neuroses DSP was conducted between October and December 2009 in the United States. The DSP methodology has been described previously in detail ( Anderson et al., 2008 ) ; an overview of the program is shown in Figure 1 . Informed consent was obtained from all patients before patient-reported information was collected. All data were anonymous; no identifi able physician or patient details were collected. Physicians and patients were assigned study numbers; matched patient/physician study numbers were used to link physician and patient responses ( Anderson et al., 2008 ) .
Physicians were recruited from public lists of health care professionals, and eligible patients were invited to participate in the DSP. Data were collected from a mixture of offi ce-based and hospital-based primary care physicians and psychiatrists. Information, including specialty, practice type, the total number of patients, the number of patients treated for anxiety and/or depression, and responsibility for treatment, was collected from each physician to determine eligibility. Physicians participating in the study were asked to complete patient record forms prospectively for 15 consecutive outpatients presenting with symptoms of depression and/or anxiety within a 1-to 2-week period ( Anderson et al., 2008 ) . Eligible patients could be seeking treatment for other medical illnesses or symptoms but must also present symptoms of depression and/or anxiety. Clinician-reported information regarding demographics, symptoms, diagnosis, treatment approaches, and factors that infl uenced therapy selection was collected for each patient in a diary format (see Table 1 , Supplemental Digital Content, available at: http://links.lww.com/PCM/A5). To collect matched patient-physician information, the same patients were then invited to fi ll out a self-completion form, providing their own assessment of symptoms, expectations, and quality of life ( Anderson et al., 2008 ) . Patients provided information independently of and without their physician present. Physicians also provided workload information based on all patient consultations for each of the fi rst 5 days of the study period (see Table 1 , Supplemental Digital Content, available at: http://links.lww.com/PCM/A5).
Study Participants
Eligible clinicians included primary care physicians and psychiatrists personally responsible for treatment decisions for patients with anxiety and/or depression symptoms. To generate a nationally representative sample, a larger number of physicians were recruited from densely populated areas compared with more sparsely populated areas ( Anderson et al., 2008 ) . Recruitment criteria required that primary care physicians must see at least 10 outpatients and psychiatrists must see at least 20 outpatients per week who suffer from anxiety/depression/neurosis symptoms. Physicians must also be personally responsible for treatment decisions regarding drug therapy for these patients. All patients were recruited independent of drug therapy or an anxiety and depression diagnostic label, and could be taking prescribed drug therapy, nondrug therapy, or both.
Outcomes
The primary outcome measure was the Clinical Global Impressions-Improvement (CGI-I) scale. The CGI-I is a single-question instrument that uses a 7-point rating scale designed to assess how much a patient's illness has reduced or worsened with treatment ( Guy, 1976 ) . The scale instructions state that the physician is to "rate total improvement whether or not, in your judgment, it is due entirely to drug treatment" ( Guy, 1976, p.218 ) . In response to the question "Compared to his condition at admission to the project [treatment] , how much has he changed?" the rater selects 0 = not assessed , 1 = very much improved , 2 = much improved , 3 = minimally improved , 4 = change , 5 = minimally worse , 6 = much worse , or 7 = very much worse ( Guy, 1976 ) . Physicians completed the CGI-I for each patient included in the study. Matched patients also completed the Patient Global Impressions-Improvement (PGI-I) scale ( Guy, 1976 ) , independently of their physician. Patient and physician responses were compared, and concordance between matched pairs was assessed. Assessment of adherence to prescribed medication was based on the physician's rating; physicians were asked to respond with "takes all medicine always," "almost always," "misses doses regularly," or "misses doses almost always." The Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form (Endicott, Nee, Harrison, & Blumenthal, 1993 ) was used to determine patient satisfaction with treatment regimen, and patient perception of their quality of life was measured using the EuroQol 5 Dimension (quality of life and utility measure) and the EuroQol 5 Dimension Visual Analog Scale instrument (EuroQol Group, 1990) .
Statistical Analysis
Patient demographic data and clinical characteristics, including symptom severity according to the physicians' assessment, were summarized for the total population and by condition. Patients presenting with symptoms of depression and/or anxiety were Each variable had a different base for analysis, because some variables had differing patterns of "not stated" values. For "home circumstances" and "employment status," multiple responses were acceptable (e.g., retired and homemaker). Therefore, the sum of frequencies for each response may exceed the base shown. categorized into four groups based on their condition, including pure depression, pure anxiety, anxiety and depression, or neither. Continuous variables were described by their mean and standard deviation in each of the patient groups, and differences between these groups were tested using analysis of variance. Categorical variables were described using frequency and percentage in each of the patient groups, and differences were assessed using chi-square tests. All percentages were calculated after removing missing responses. Ordinal variables, or continuous variables that did not follow a normal distribution, were tested for differences across patient groups by using Kruskal-Wallis tests. The level of agreement between the responses for the CGI-I and PGI-I scale, and the physician and patient responses to the level of adherence to prescribed medication was assessed using Cohen's kappa statistics (Landis & Koch, 1977) . Agreement between the CGI-I and PGI-I scale was also assessed in patients categorized as having mild (scores of 1 or 2), moderate (score of 3), or severe (scores of 4 or 5) illness, using the same methods.
All of the described analyses were conducted using STATA version 12.1 (StataCorp LP, College Station, TX).
R ESULTS
A total of 180 physicians participated in the study, including 100 primary care physicians and 80 psychiatrists. Physician-completed patient record forms were collected for 2,704 patients; self-completion records were available for 1,486 patients.
Patient demographics and clinical characteristics based on physician-completed records are summarized by presenting symptoms of anxiety and/or depression in Table 1 . Most patients were women (64%); the mean age of all patients in the study was 46 years. A majority of patients lived alone or with family and friends and were employed full-time.
Results of the physician-and patient-rated improvement in illness, based on the CGI-I and PGI-I scales, respectively, are shown in Tables 2 and 3 , Supplemental Digital Content, available at: http://links.lww.com/ PCM/A5. Most physicians (82%) and patients (89%) had an overall impression of improvement when considering all patients with combined mild, moderate, and severe illness. Impression of improvement by physicians progressively decreased with increased severity of illness (i.e., mild, 89%; moderate, 79%; severe, 66%; see Table 2 , Supplemental Digital Content, available at: http://links.lww.com/PCM/A5). Patient perception of improvement was similar for mild (92%) and moderate disease (89%) and decreased to 80% for patients with severe disease (see Table 3 , Supplemental Digital Content, available at: http://links.lww.com/PCM/A5).
Results of the kappa analysis assessing the level of agreement between the responses for the CGI-I and PGI-I scales demonstrated fair agreement between patients and physicians regarding overall impression of improvement in illness (44% agreement; κ = 0.23). Patients reported less satisfaction with treatment compared with physicians when the physician reported high levels of improvement (see Figure 2 ) . Overall, physician estimates matched patient-reported improvements in 44% of all matched cases, were lower than the patient report in 37% of matched cases, and were higher in 18% of matched cases.
No differences were observed in comparisons of levels of agreement among psychiatrists (45% agreement; κ = 0.25) versus primary care physicians (44% agreement; κ = 0.22). However, psychiatrists reported greater improvement than their patients more frequently than primary care physicians ( p < .05). Patient satisfaction and quality of life as measured by the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form and the EuroQol 5 Dimension indicated that this same group of patients had lower satisfaction with their treatment and reduced quality of life (see Table 2 ). The medication relieves the most troublesome symptoms (n = 1,035)
Very dissatisfi ed 12 (3) 10 (5) 16 (4) A little dissatisfi ed 20 (4) 16 (9) 15 (4) A little satisfi ed 112 (24) 52 (28) 77 (20) Very satisfi ed 238 (51) 79 (42) 204 (53) Extremely satisfi ed 83 (18) 22 (12) 70 (18) The medication improves my condition ( n = 1,026)
Very dissatisfi ed 11 (2) 11 (6) 11 (3) A little dissatisfi ed 24 (5) 14 (8) 18 (5) A little satisfi ed 98 (21) 57 (31) 72 (19) Very satisfi ed 244 (53) 77 (41) 197 (52) Extremely satisfi ed 87 (19) 20 (11) 76 (20) The medication keeps me from feeling worse ( n = 1,015)
Very dissatisfi ed 9 (2) 10 (5) The medication is convenient to take in terms of fi tting into my schedule ( n = 1,024)
Extremely dissatisfi ed 4 (1) 2 (1) 1 (0.3) .919
Very dissatisfi ed 4 (1) 5 (3) 8 (2) A little dissatisfi ed 20 (4) 7 (4) 8 (2) A little satisfi ed 74 (16) 26 (14) 52 (14) Very satisfi ed 204 (45) 83 (44) 192 (51) Extremely satisfi ed 151 (33) 65 (35) 118 (31) It is easy to remember to take the medication ( n = 1,018)
Extremely dissatisfi ed 5 (1) 1 (1) 3 (1) .855
Very dissatisfi ed 6 (1) 5 (3) 9 (2) A little dissatisfi ed 33 (7) 18 (10) 21 (6) A little satisfi ed 75 (16) 25 (13) 70 (19) Very satisfi ed 201 (44) 83 (45) 168 (45) Extremely satisfi ed 136 (30) 54 (29) 105 (28) Side effects I experience ( n = 999)
Extremely dissatisfi ed 4 (1) 6 (3) 3 (1) .0001
Very dissatisfi ed 13 (3) 12 (7) 14 (4) A Cost of the medication ( n = 1,016)
Extremely dissatisfi ed 10 (2) 7 (4) 16 (4) .314
Very dissatisfi ed 34 (8) 15 (8) 30 (8) A little dissatisfi ed 63 (14) 33 (18) 50 (13) A little satisfi ed 108 (24) 41 (22) 91 (24) Very satisfi ed 150 (33) 55 (30) 134 (35) Extremely satisfi ed 88 (19) 33 (18) 58 (15) Overall satisfaction with the medication ( n = 1,021)
Extremely dissatisfi ed 0 (0) 9 (5) (51) 70 (40) 185 (52) Very good 82 (19) 19 (11) 70 (20) Q-LES-Q-SF: satisfaction with life overall, n (%) d,e ( n = 1,003)
Very poor 4 (1) 9 (5) 6 (2) < .0001
Poor 22 (5) 22 (12) 32 (9) Fair 157 (35) 78 (43) 121 (33) Good 196 (44) 60 (33) 163 (44) Very good 69 (15) 14 (8) 50 (13) EQ-5D score, mean (SD) Kruskal-Wallis tests were used to assess statistical signifi cance. c Patient-recorded satisfaction with current prescribed treatment, using a scale from 1 ( extremely dissatisfi ed ) to 6 ( extremely satisfi ed ). Patient-recorded quality of life scores, using a scale from 1 ( very poor ) to 5 ( very good ) f The EQ-5D allows the patient to describe his or her health across fi ve dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) at three levels (no problem, some or moderate problems, and extreme problems). The EQ-VAS allows the patient to provide a self-rating of his or her own health using a 20-cm scale from 0 ( worst imaginable health state ) to 100 ( best imaginable health state ; Rabin & de Charro, 2001 ).
Similar to responses for improvement in illness, results of the kappa analysis evaluating physician-and patient-perceived adherence to treatment demonstrated fair agreement (58%; κ = 0.27). Physicians' rating scores indicated higher rates of treatment adherence (26% of all patients) compared with the patients' report of adherence (see Figure 3 ) .
D ISCUSSION
Collection of real-world data is an important component of understanding the behaviors and attitudes that drive utilization of available treatments in practice. Since their inception in 1995, DSPs have been conducted in more than 40 different disease areas and have provided valuable insights into the current treatment practices for these conditions ( Anderson et al., 2008 ) . In this study, a Neuroses DSP was conducted using an international sample of 2,704 patients with anxiety and/or depression and in treatment by 100 primary care physicians and 80 psychiatrists, to compare physician-rated and patient-related improvement in illness as measured by the CGI-I and PGI-I scales. Although the level of agreement reported by physicians and patients was fair (44%), physicians reported lesser improvement than patients' reports in 37% of cases and greater improvement in 18% of cases.
Our real-world data of substantial discrepancies between clinician and patient ratings of depression are concordant with previous fi ndings from numerous research studies (Carter, Frampton, Mulder, Luty, & Joyce, 2010; Corruble, Legrand, Zvenigorowski, Duret, & Guelfi , 1999; Domken, Scott, & Kelly, 1994; Dorz, Borgherini, Conforti, Scarso, & Magni, 2004; Enns, Larsen, & Cox, 2000; Zastrow et al., 2008 ) . Many of these studies have identifi ed patient factors that may contribute to underestimation or overestimation of physician scores relative to patient ratings. The importance of understanding physician-patient agreement was suggested by a subsequent publication of the Prevention of Recurrent Episodes of Depression With Venlafaxine Extended Release for Two Years data comparing the patient-rated Inventory of Depressive Symptoms-Self-Report versus the clinician-rated 17-item Hamilton Rating Scale for Depression and the Clinical Global Impressions-Severity Scale ( Dunlop et al., 2010 ) . Dunlop et al. (2011) reported that poor levels of patient-physician agreement might predict slower time to response. In addition, female patients were more likely to overrate their depression severity during the short-term treatment phase of the Prevenpatient-related and clinician-rated measures is not always evident such that self-rated scales have been advocated as a convenient alternative. Data obtained from the Sequenced Treatment Alternatives to Relieve Depression study demonstrated that the self-rated 16-item Quick Inventory of Depressive Symptomatology (i.e., patient-rated Quick Inventory of Depressive Symptomatology interactive voice response measures) was a suitable replacement for the clinician-rated 17-item Hamilton Rating Scale for Depression in outpatients with nonpsychotic major depressive disorder without overt cognitive impairment (Rush, Bernstein, et al., 2006) .
In this study, physician-and patient-rated overall improvement in illness was 82% and 89%, respectively. This includes all phases of improvement as assessed by the CGI-I and PGI-I scales, including "very much improved," "much improved," and "minimally improved" for the physician-rated improvement and "very much better," "much better," and "a little better" for patient self-reports. However, these percentages are somewhat less favorable when omitting the "minimally improved" from the physician ratings scale and "a little better" from the self-reporting scale. These data are consistent with previous studies that demonstrate a signifi cant percentage of patients who fail to experience clinical improvement .
One important observation of this study is that patients completed the patient self-completion questionnaire after their consultation with the physician. Having the patient report ratings after the physician consultation may increase the chance for agreement, specifi cally in patients who presented with symptoms of depression and/or anxiety. One can assume that these patients have shared a conversation about their symptoms with the physician, thus helping bring a shared vision to the situation. However, it is important to note that these patient-physician conversations may lead to further disparity if the physician assumes that the patient is in agreement with the proposed treatment plan simply on the basis of these discussions, when in fact the patient may be afraid to disagree with the physician. This report has several limitations, including potential selection bias, because the analysis for this article involved only those patients being treated by physicians who participated in the DSP, and the study focused on anxiety and depression. In addition, because the study was based on consulting patients, patients who sought consultations more frequently had a greater chance of being included. Other limitations of this report include the lack of a formal diagnostic procedure, and the lack of a control group. Moreover, only a cross-section of data was collected with no ability to identify cause and effect or changes over time.
CONCLUSION
Real-world data suggest that reduction in symptoms of anxiety and/or depression may be estimated differently by physicians when compared with the perception of their patients. This observation may be explained by the physicians' perception that each patient may achieve a certain amount of improvement from a specifi c drug rather than measuring improvement on a patient-by-patient basis. In addition, the disparity between patients and their physicians may be related to the agreed-upon severity of symptoms during the initial visit. Ultimately, on the basis of an initial miscommunication, the patient may not be diagnosed appropriately and prescribed the optimal therapy, thus leading to discrepancies in the perception of improvement.
Implications for Case Management
Overall, these fi ndings are consistent with research reports in the literature and should be considered when assessing treatment and practice patterns. Because these disparities exist between physicianand patient-rated measures of depression in the clinical setting, it is critical for physicians to examine the tools and methods used for evaluating symptoms and improvement in an effort to maximize treatment adherence and overall patient outcomes. Moreover, understanding the potential for disparities between physician-and patient-rated measures in reviewing patient care can help the case manager ensure that treatment plans are aligned with patient needs. Collaborative care can reduce depressive symptoms and improve functional outcomes compared with standard care in depressed patients ( Katon et al., 2005 ; Katon & Guico-Pabia, 2011 ) without signifi cantly increasing overall medical costs ( Katon et al., 2005 ( Katon et al., , 2008 , and effective patient assessment and followup are key aspects of the collaborative care model (Katon & Guico-Pabia, 2011) . Case management workers trained to use assessment instruments can monitor progress on the basis of both physician and patient perspectives, and fl ag issues to report to primary care physicians or psychiatrists as needed.
Case management workers trained to use assessment instruments can monitor progress on the basis of both physician and patient perspectives, and fl ag issues to report to primary care physicians or psychiatrists as needed.
